Gene · 2877
Papers1,817
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 1,817
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metabolism of Selenium, Selenocysteine, and Selenoproteins in Ferroptosis in Solid Tumor Cancers. | Biomolecules | 2022 | 36358931 | PubTator, text mining | PubMed |
| Ameliorative Effect of Tocotrienols on Perimenopausal-Associated Osteoporosis-A Review. | Antioxidants (Basel) | 2022 | 36358550 | PubTator, text mining | PubMed |
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
| Pitfalls in complement analysis: A systematic literature review of assessing complement activation. | Front Immunol | 2022 | 36330514 | PubTator, text mining | PubMed |
| Tumor heterogeneity and the dilemma of antioxidant therapies in cancer. | Ann Transl Med | 2022 | 36330399 | PubTator, text mining | PubMed |
| Effective prediction of potential ferroptosis critical genes in clinical colorectal cancer. | Front Oncol | 2022 | 36324584 | PubTator, text mining | PubMed |
| ROS: Basic Concepts, Sources, Cellular Signaling, and its Implications in Aging Pathways. | Oxid Med Cell Longev | 2022 | 36312897 | PubTator, text mining | PubMed |
| GPX2 predicts recurrence-free survival and triggers the Wnt/β-catenin/EMT pathway in prostate cancer. | PeerJ | 2022 | 36312753 | PubTator, text mining | PubMed |
| Dysregulation of SOX17/NRF2 axis confers chemoradiotherapy resistance and emerges as a novel therapeutic target in esophageal squamous cell carcinoma. | J Biomed Sci | 2022 | 36310172 | PubTator, text mining | PubMed |
| Pesticides and Their Impairing Effects on Epithelial Barrier Integrity, Dysbiosis, Disruption of the AhR Signaling Pathway and Development of Immune-Mediated Inflammatory Diseases. | Int J Mol Sci | 2022 | 36293259 | PubTator, text mining | PubMed |
| Sphingosine-1-Phosphate Alleviates Irradiation Induced Salivary Gland Hypofunction through Preserving Endothelial Cells and Resident Macrophages. | Antioxidants (Basel) | 2022 | 36290773 | PubTator, text mining | PubMed |
| Transcriptomic Analysis of Genes Associated with Oxidative Stress in Chronic Rhinosinusitis Patients with Nasal Polyps: Identifying Novel Genes Involved in Nasal Polyposis. | Antioxidants (Basel) | 2022 | 36290622 | PubTator, text mining | PubMed |
| Hydroxy-Selenomethionine, an Organic Selenium Source, Increases Selenoprotein Expression and Positively Modulates the Inflammatory Response of LPS-Stimulated Macrophages. | Antioxidants (Basel) | 2022 | 36290599 | PubTator, text mining | PubMed |
| Nrf2 Modulation in Breast Cancer. | Biomedicines | 2022 | 36289931 | PubTator, text mining | PubMed |
| The Roles of microRNA miR-185 in Digestive Tract Cancers. | Noncoding RNA | 2022 | 36287119 | PubTator, text mining | PubMed |
| Regulators of epigenetic change in ferroptosis‑associated cancer (Review). | Oncol Rep | 2022 | 36281949 | PubTator, text mining | PubMed |
| Identification of distinct circulating microRNAs in acute ischemic stroke patients with type 2 diabetes mellitus. | Front Cardiovasc Med | 2022 | 36277770 | PubTator, text mining | PubMed |
| Redox regulation of hybrid metabolic state in breast cancer metastasis. | Ann Transl Med | 2022 | 36267744 | PubTator, text mining | PubMed |
| Tumor microenvironment-related gene selenium-binding protein 1 (SELENBP1) is associated with immunotherapy efficacy and survival in colorectal cancer. | BMC Gastroenterol | 2022 | 36253721 | PubTator, text mining | PubMed |
| ZBTB7A promotes virus-host homeostasis during human coronavirus 229E infection. | Cell Rep | 2022 | 36243002 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2877/papers?page=16